News - Pharmaphorum

Latest News

in News News News

Novo’s diabetes pill beats injections in head-to-head trials
June 22, 2018 Share
X
Novo’s diabetes pill beats injections in head-to-head trials
https://pharmaphorum.com/news/novo-nordisks-success-with-oral-diabetes-drug/
in News News

Tesaro stock rockets as rumours of Roche takeover abound
June 22, 2018 Share
X
Tesaro stock rockets as rumours of Roche takeover abound
https://pharmaphorum.com/news/tesaro-stock-rockets-roche-takeover-abound/
in News News

Industry urges EU to scrap national HTA bodies
June 22, 2018 Share
X
Industry urges EU to scrap national HTA bodies
https://pharmaphorum.com/news/industry-urges-eu-to-scrap-national-hta-bodies/
in News News

Amazon hires surgeon to lead US healthcare revolution
June 21, 2018 Share
X
Amazon hires surgeon to lead US healthcare revolution
https://pharmaphorum.com/news/amazon-hires-surgeon-to-lead-us-healthcare-revolution/

Industry urges EU to scrap national HTA bodies

Influential EU committee discusses proposals today

Industry urges EU to scrap national HTA bodies

https://pharmaphorum.com/news/industry-urges-eu-to-scrap-national-hta-bodies/

Amazon hires surgeon to lead US healthcare revolution

Atul Gawande is new CEO of joint venture

Amazon hires surgeon to lead US healthcare revolution

https://pharmaphorum.com/news/amazon-hires-surgeon-to-lead-us-healthcare-revolution/

Opioid misuse lead to at least 456 deaths in UK hospital

Care standards and ethics in the NHS are once again under scrutiny after a report found that overprescription

Opioid misuse lead to at least 456 deaths in UK hospital

https://pharmaphorum.com/news/opioid-kills-gosport-hospital-patients-uk/

See all

This week’s news

Wellcome Trust awards $8bn cash injection to trial schizophrenia drug

The Wellcome Trust has awarded $8 million to PureTech’s Karuna to take its schizophrenia drug into mid-stage trials.

Wellcome Trust awards $8bn cash injection to trial schizophrenia drug

https://pharmaphorum.com/news/wellcome-trust-awards-trial-schizophrenia-drug/

Amgen’s blood cancer drug gets full EU licence

FDA granted full licence last year

Amgen’s blood cancer drug gets full EU licence

https://pharmaphorum.com/news/amgens-blood-cancer-drug-blincyto-licence/

Roche to buy rest of genetics firm Foundation Medicine

Roche has made an offer to buy the remaining shares in cancer genetics firm Foundation Medicine (FMI) for

Roche to buy rest of genetics firm Foundation Medicine

https://pharmaphorum.com/news/roche-buys-shares-foundation-medicine/

Sarepta goes up, PTC goes down – DMD research sways the market

US biotech Sarepta’s shares jumped by as much as 60% after a gene therapy produced dramatic results in

Sarepta goes up, PTC goes down – DMD research sways the market

https://pharmaphorum.com/news/dmd-therapy-research-sways-market/

Patients call for end to two-year row over CF drug funding

UK patients are stepping up efforts to resolve the “heartbreaking” row that is denying their families access to

Patients call for end to two-year row over CF drug funding

https://pharmaphorum.com/news/patients-call-for-end-to-two-year-row-over-cf-drug-funding/

PTC shares soar after SMA drug data impresses market

After failing three times to bring their Duchenne therapy to the US market, PTC Therapeutics might be on

PTC shares soar after SMA drug data impresses market

https://pharmaphorum.com/news/ptc-therapeutics-posts-solid-sma-data/

NICE says ‘no’ to Roche’s Perjeta after breast cancer surgery

NICE consulting on first draft decision

NICE says ‘no’ to Roche’s Perjeta after breast cancer surgery

https://pharmaphorum.com/news/nice-says-no-to-roches-perjeta-after-breast-cancer-surgery/

Theresa May’s NHS funding pledge insufficient – campaigners

Campaigners have said Prime Minister Theresa May’s pledge to boost NHS coffers by £20 billion a year will

Theresa May’s NHS funding pledge insufficient – campaigners

https://pharmaphorum.com/news/more-questions-than-answers-after-mays-nhs-cash-pledge/

Former Theranos CEO faces criminal fraud charges

Elizabeth Holmes, the founder and former CEO of the blood testing startup Theranos has been criminally charged with

Former Theranos CEO faces criminal fraud charges

https://pharmaphorum.com/news/former-theranos-ceo/

Eisai accelerates dementia drug discovery research

Eisai is launching a special dementia discovery centre to boost development of next-generation medicines targeting forms of the

Eisai accelerates dementia drug discovery research

https://pharmaphorum.com/news/eisai-dementia-drug-research/

Novartis ranked top for corporate reputation in dermatology

Novartis has been ranked the top pharma company in dermatology in a corporate reputation survey of skin condition

Novartis ranked top for corporate reputation in dermatology

https://pharmaphorum.com/news/novartis-corporate-reputation-dermatology/

Positive results announced for ViiV Healthcare’s two-drug HIV pill

A two-drug strategy has shown positive results, giving new hope to patients with HIV. ViiV Healthcare, which is

Positive results announced for ViiV Healthcare’s two-drug HIV pill

https://pharmaphorum.com/news/positive-results-hiv-pill/

J&J’s Tremfya gets funding in Germany and UK

Johnson & Johnson’s psoriasis drug Tremfya has been given the green light for funding by cost-effectiveness bodies in

J&J’s Tremfya gets funding in Germany and UK

https://pharmaphorum.com/news/jjs-tremfya-funding-germany-uk/

J&J seals $2.1bn deal on sale of major diabetes devices firm

As part of its ongoing divestment program, a deal worth $2.1 billion has been struck between Johnson &

J&J seals $2.1bn deal on sale of major diabetes devices firm

https://pharmaphorum.com/news/jj-deal-glucose-monitoring-system/

Orphan drugs dominate 2018 UK Prix Galien shortlist

A bumper crop of orphan drugs from the likes of Amicus, Kyowa Kirin, Eusa and Biogen dominates this

Orphan drugs dominate 2018 UK Prix Galien shortlist

https://pharmaphorum.com/news/orphan-drugs-uk-prix-galien-shortlist/

Partner content

Press releases

Registration is open for the 9th Annual Biosimilars & Biobetters 2018 Event

https://pharmaphorum.com/partner-content/registration-is-open-for-the-9th-annual-biosimilars-biobetters-2018-event/

Agenda Released for USA Biosimilars Conference this November

https://pharmaphorum.com/partner-content/agenda-released-for-usa-biosimilars-conference-this-november/

New Speakers from Roche & Imperial College announced for SMi’s ADMET Event

https://pharmaphorum.com/partner-content/new-speakers-from-roche-imperial-college-announced-for-smis-admet-event/

Digital marketing automation with eWizard and Salesforce Marketing Cloud integration

https://pharmaphorum.com/partner-content/digital-marketing-automation-with-ewizard-and-salesforce-marketing-cloud-integration/

See all

Appointments

Wellcome Genome Campus Hackathon 2-3 July

https://pharmaphorum.com/partner-content/wellcome-genome-campus-hackathon-2-3-july/

Matt De Gruchy joins Reynolds Mackenzie as new agency CEO

https://pharmaphorum.com/partner-content/matt-de-gruchy-joins-reynolds-mackenzie-as-new-agency-ceo/

See all

Search

Advanced Search

Trending

Latest News

This week’s news

Press releases

Appointments